# Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA)

> **NCT07055230** · — · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 67 (actual)

## Conditions studied

- Allergic Bronchopulmonary Aspergillosis (ABPA)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07055230
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-08
- **Primary completion:** 2024-02-02
- **Final completion:** 2024-08-02
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07055230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07055230, "Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07055230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*